Dr. Rodrigo Aguayo-Romero (WW) receives NIH K01 grant to link transgender women in Ecuador to HIV prevention and care | |
|
Please join us in congratulating Dr. Aguayo-Romero (they/them/elle) on their receipt of a new K01 award! The K01 was awarded by the National Institutes for Mental Health (NIMH). Rodrigo Aguayo-Romero, PhD, is a Research Scientist at the Whitman-Walker Institute.
The grant is entitled, "Intersectional discrimination and linkage to HIV prevention and care in transgender women in Ecuador." This research will assess the mechanisms through which intersectional discrimination exerts its impact on linkage to HIV prevention and care for transgender women in Ecuador while extending and deepening the PI's research skills.
The aims of the study include 1) assessing experiences of intersectional discrimination of transgender women in Ecuador through in-depth qualitative interviews; 2) surveying to characterize and longitudinally test the pathways that link intersectional discrimination with HIV prevention and care linkage outcomes; and 3) implementing the first six phases of the systematic ADAPT-ITT model to adapt an HIV intervention for transgender women.
Read more regarding their award here.
| |
Dr. Manya Magnus receives NIH R01 Award as an MPI for an RCT of Client-Centered Care Coordination (C4) to Improve PrEP Use in Black MSM. |  | |
Please join us in congratulating Dr. Magnus (GW; center left) on her receipt of a new R01 award as an MPI with colleagues Dr. Darren Whitfield (Contact PI; Left) from the University of Maryland, Baltimore and Dr. LaRon E. Nelson (MPI; center right) from Yale University. Congratulations also to Dr. DeMarc Hickson (site PI; right) as the study will be implemented at two sites including Us Helping Us, People Into Living. The R01 was awarded by the National Institutes for Mental Health (NIMH). Manya Magnus, PhD, MPH, is Professor and Interim Chair of the Department of Epidemiology at GW and Co-Director of the DC CFAR.
The grant is entitled, "A randomized clinical trial of client-centered care coordination to improve pre-exposure prophylaxis use for Black men who have sex with men." This study will further the research done in HPTN 073 within the GW HIV Prevention Trials Network Clinical Research site, which is a collaboration between the GW SPH, the GW MFA under the leadership of Dr. Marc Siegel (Co-Director, CPS Core), and along with other faculty, GW students, staff, and community.
Aims of this randomized trial are to characterize the associations between client centered care coordination (C4) and PrEP uptake and adherence among Black men who have sex with men, and to describe the acceptability and feasibility of C4 implementation in community settings in Washington DC and New York.
Read more regarding the award here.
| |
I-SURC In-Person Networking Meeting Registration: Travel Scholarships Available for ESIs* | |
The Inter-CFAR Substance Use Research Community (I-SURC) is hosting an in-person networking event at CROI 2024 on Sunday, March 3, 2024. The meeting will take place at The Slate Hotel, Denver, CO, from 12:30 to 4:30pm and will include lunch.
The goals of the meeting are to deepen member engagement in the I-SURC; create mentoring and networking opportunities for early stage investigators; catalyze new collaborations; and outline priorities for future research on substance use and HIV.
Attendees will participate in dedicated networking sessions based on their
research interests.
*A limited number of travel awards are available on a rolling basis with priority given to CFAR-affiliated early stage investigators.
For any questions, please contact Natalia Gnatienko. See the flyer announcement here.
Register for the meeting here.
| | |
Mid-Atlantic CFAR Consortium (MACC) Scholars Program RFA: Applications due Dec 15, 2023 | |
The Mid-Atlantic Centers for AIDS Research Consortium (MACC) Scholars Program is excited to announce this invitation to apply to be a MACC Scholar in the third cohort of early stage career investigators. The MACC Scholars Program is a collaboration between the District of Columbia (DC) CFAR, the Johns Hopkins University (JHU) CFAR, and the University of Pennsylvania (UPenn) CFAR.
The goal of the MACC Scholars Program is to support the development of new investigators with an interest in HIV among diverse populations in the Mid-Atlantic region, and to encourage their development as independent HIV investigators.
Up to $20,000 total costs can be used to implement a new pilot research project of which up to $5,000 can be used to enhance professional opportunities. This can include up to 10% faculty time if coverage is required to conduct the pilot, funds to conduct the study, attend conferences, receive leadership or scientific training, travel to other CFARs, or other costs as justified by the applicant. All Scholars will receive professional mentorship from MACC Scholar faculty at each of the collaborating CFARs and the opportunity to network with CFAR membership as they build their careers.
Please view the full RFA linked here.
Please address questions to Dr. Manya Magnus, at manyadm@gwu.edu
| |
DC CFAR Developmental Core Virtual Lecture Series – "My Path to Independence in HIV Research" ft. Dr. Imtiaz Khan, Tues, Jan 16, 4:00-5:00 pm EST | |
Please join us for the DC CFAR Developmental Core Lecture Series: My Path to Independence in HIV Research. Each hour-long lecture in this series showcases prominent researchers who share autobiographical accounts of their careers in HIV research, specifically their pathways to career and research independence
Our next lecture will feature Dr. Imtiaz Khan, Professor of Microbiology, Immunology, and Tropical Medicine at George Washington. Please join us as we learn what sparked his interest in HIV research and the mentors, obstacles, and resources that helped direct and shape his path to success. For more information, please find his academic profile here.
Register for the event here.
| | |
Do you have an event you would like to see included in the next edition of the Community Spotlight? We invite any news or updates from the DC CFAR community and encourage you to send information that may be of interest to CFARinDC@gmail.com. | |
|
SYNC 2024: Registration Now Open & Call for Abstracts
May 29-31, 2024
Washington, DC
CROI: Conference on Retroviruses and Opportunistic Infections 2024 (Abstract Submission here)
March 3-6, 2024
Denver, CO
Save the Date – National 2024 Ryan White Conference on HIV & Treatment (AIDSWatch)
March 17-19, 2024
Washington, DC
IAS 2024 – Registration Now Open
July 22-26
Munich, Germany
National LGBTQ+ Health Conference
August 15-17, 2024
Atalanta, GA
2024 National Ryan White Conference on HIV Care & Treatment
August 20-23, 2024
For more DC CFAR events please see the calendar here.
| |
FUNDING, TRAINING, & MENTORING OPPORTUNITIES/SEMINARS | |
|
DC CFAR Virtual Writing Retreat (Every 3rd Friday of the Month, 12-2:00PM EST via Zoom);
"Whether a report, journal article, grant application, or other document, we often struggle with carving out space in our busy calendars for uninterrupted work. Bring a writing project and join us monthly! Have questions? Reach out to Wendy Davis (wendywdavis@gwu.edu) or Allison O’Rourke (orourkea@gwu.edu)" Register here to receive Zoom information.
DC CFAR Aging & Co-Morbidities Scientific Interest Group Open Meeting – REPRIEVE Trial
Please join the Aging and Co-morbidies SIG on December 13th, from 5-6PM EST via Zoom for a presentation from Lynsay Ehui (WW) on the REPRIEVE Trial. This meeting is being held on Zoom.
NEW – NIDA HIV Seminar Series with Dr. Sandra Springer, Jan 24, 2024 1PM EST
Join the NIDA HIV Research Program for the upcoming NIDA HIV Seminar with Dr. Sandra Springer of Yale School of Medicine, 2022 recipient of the NIDA HIV Avant-Garde Award, for her presentation "Integrating Addiction and HIV Prevention and Treatment for Everyone and Bringing it to Where They Live." Sandra Springer, M.D., is a Professor of Medicine at the Yale School of Medicine. Her research integrates aspects of substance use and infectious diseases, with a focus on opioid use disorder treatment and the treatment and prevention of HIV among people with carceral experience. Click the link for the Zoom registration here.
Skills for Health and Research Professionals (SHARP) Training - Scholarship Application
Our SHARP Program consists of short, intensive boot camps led by field experts to teach in-demand research skills and methods to investigators at all career levels and from any organization. Scholarship awards cover at least 50% of the registration fee, increasing the accessibility and participation of early-stage researchers and professionals in learning in-demand field methods.
SYNC 2024: Registration Now Open & Call for Abstracts
SYNChronicity (SYNC) 2024, the national conference for HIV, HCV, STIs, Harm Reduction, and LGBTQ Health will take place in Washington DC, May 29-31, 2024. SYNC 2024 will focus on SYNCing to end the epidemics by driving discussion and strategy development around the innovation and implementation necessary to make an impact. For conference details and information on submitting an abstract (abstracts are due January 31, 2024) please visit SYNC2024.org.
HPTN Scholars Program (2024-2025 Cohort)
"The HIV Prevention Trials Network (HPTN) is proud to offer two scholarship programs for early-career investigators funded through a supplement from the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute on Drug Abuse (NIDA), and the National Institute of Mental Health (NIMH). The HPTN Scholars Program now includes two components: a domestic (U.S.) program and an international program. Both programs seek to increase opportunities for scientists from groups under-represented in HIV prevention research." More information available here.
HIV Vaccine Trials Network: Research and Mentorship Program (RAMP)
"Seeking African American/Black, Hispanic/Latinx, Native American/American Indian/Alaska Native, Native Hawaiian, Asian and Pacific Islander medical students interested in HIV vaccine research. The HIV Vaccine Trials Network (HVTN) is now accepting applications for Research and Mentorship Program (RAMP) Scholar Grants to attract Black, Indigenous and other People of Color (BIPOC) medical students who want to make a difference in their communities and contribute to the development of an effective HIV vaccine." Applications due January 2, 2024. See more information here.
| |
OTHER OPPORTUNITIES, NEWS, AND RESOURCES
| |
|
Vanderbilt recruiting HIV researchers to join faculty
The Tennessee CFAR is recruiting for two faculty positions in HIV research. 1) Faculty Position in HIV Social and Behavioral Science and 2) Faculty Position in HIV and Aging Research. Please click the respective links for more details.
CDC Opening, Senior Service Fellow (Epidemiologist) in the Division of Health and Nutrition Examination Surveys (DHANES)
“As a member of DHANES’ Analysis Branch, the Service Fellow will conduct analyses with NHANES data (for example, analysis of infectious disease or chronic disease outcomes). In collaboration with other researchers within and outside of NCHS, the fellow will plan and implement high-quality research on health topics after selecting appropriate statistical and epidemiologic methods. The fellow will prepare comprehensive reports of study results for NCHS and scientific publication and present research activities at professional conferences and meetings. In addition, the fellow will contribute to the division by conducting ad hoc analyses, participating in workgroups, answering public inquiries, and other tasks as needed.”
| |
NIH FUNDING OPPORTUNITIES
| |
|
NEW – Addressing the Impact of Syndemics on the Health of People with HIV and Diseases and Conditions within the Missions of NIDDK and NHLBI (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DK-25-001
Posting Date: November 30, 2023
Opening Date: February 20, 2024
Close Date: Various – See announcement
Engineering and Preclinical Development of Biological Products that Eliminate HIV-infected Cells (UG3/UH3 Clinical Trial Not Allowed)
Funding Opportunity Number: RFA-AI-23-060
Posting Date: October 25, 2023
Opening Date: February 13, 2024
Close Date: March 14, 2024
Addressing the Impact of Structural Racism and Discrimination on Minority Health and Health Disparities (R01 - Clinical Trial Optional)
Funding Opportunity Number: PAR-23-112
Posting Date: January 31, 2023
Opening Date: February 24, 2023
Close Date: Various – See announcement
Engaging Survivors of Sexual Violence and Trafficking in HIV and Substance Use Disorder Services (R34 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-018
Posting Date: August 21, 2023
Opening Date: July 5, 2024
Close Date: August 2024
Addressing HIV in Highest Risk Sexual and Gender Minorities (R01 Clinical Trial Optional)
Funding Opportunity Number: RFA-DA-25-001
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
Addressing HIV in highest risk sexual and gender minorities (R34 Clinical Trial Required)
Funding Opportunity Number: RFA-OD-23-018
Posting Date: July 31, 2023
Opening Date: July 14, 2024
Close Date: August 14, 2024
Notice of Special Interest (NOSI): Research on HIV-associated Malignancies
Funding Opportunity Number: NOT-CA-23-070
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
| |
|
NEW - NIAID New Innovators Awards (DP2 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-198
Posting Date: June 02, 2023
Opening Date: September 13, 2023
Close Date: Various – See announcement
NIAID Research Education Program Advancing the Careers of a Diverse Research Workforce
Funding Opportunity Number: PAR-23-282
Posting Date: November 03, 2023
Opening Date: December 26, 2023
Close Date: Various – See announcement
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R01 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-297
Posting Date: September 19, 2023
Opening Date: December 7, 2023
Close Date: Various – See announcement
Opportunities for HIV Cure Strategies at the Time of ART Initiation (R21 Clinical Trial Not Allowed)
Funding Opportunity Number: PAR-23-296
Posting Date: September 19, 2023
Opening Date: December 7, 2023
Close Date: Various – See announcement
Innovations to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-061
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Formative and Pilot Intervention Research to Optimize HIV Prevention and Care Continuum Outcomes (R34 Clinical Trial Optional)
Funding Opportunity Number: PAR-23-060
Posting Date: January 11, 2023
Opening Date: April 09, 2023
Close Date: January 10, 2026
Notice of Special Interest (NOSI): Implementation Science to Advance the United States HIV Prevention and Treatment Goals and the Global HIV Prevention and Treatment Targets
Funding Opportunity Number: NOT-MH-23-275
Posting Date: June 5, 2023
Opening Date: September 07, 2023
Close Date: September 08, 2026
| |
Click here for additional funding opportunities available from the National Institutes of Health. | |
The DC CFAR is an NIH funded program (P30AI117970), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NIDCR, NHLBI, NIDA, NIMH, NIA, NIDDK, NINR, NIMHD, FIC, and OAR. The content isthe responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. | | |
| | | |
